Global Metabolic Disorders Drugs Sales Market Report 2017

December 2017 | 112 pages | ID: G7C8A09102CEN
QYResearch

Abstracts

In this report, the global Metabolic Disorders Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Metabolic Disorders Drugs for these regions, from 2012 to 2022 (forecast), covering

• United States
• China
• Europe
• Japan
• Southeast Asia
• India

Global Metabolic Disorders Drugs market competition by top manufacturers/players, with Metabolic Disorders Drugs sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Zealand Pharma
• Rhythm
• OxThera
• Biophytis
• Biophytis
• Zafgen
• PerkinElmer
• Eternygen
• Pronutria Biosciences
• MedGenome
• CellCentric
• Nimbus Therapeutics
• Mitobridge
• Exelixis, Inc.
• Outpost Medicine
• Anchor Therapeutics
• Verva Pharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Tablet
• Injection

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Diabetes
• Disorders of the Thyroid and Pituitary Gland
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Metabolic Disorders Drugs Sales Market Report 2017

1 METABOLIC DISORDERS DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Metabolic Disorders Drugs
1.2 Classification of Metabolic Disorders Drugs by Product Category
  1.2.1 Global Metabolic Disorders Drugs Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 Global Metabolic Disorders Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Tablet
  1.2.4 Injection
1.3 Global Metabolic Disorders Drugs Market by Application/End Users
  1.3.1 Global Metabolic Disorders Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022)
  1.3.2 Diabetes
  1.3.3 Disorders of the Thyroid and Pituitary Gland
  1.3.4 Other
1.4 Global Metabolic Disorders Drugs Market by Region
  1.4.1 Global Metabolic Disorders Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 United States Metabolic Disorders Drugs Status and Prospect (2012-2022)
  1.4.3 China Metabolic Disorders Drugs Status and Prospect (2012-2022)
  1.4.4 Europe Metabolic Disorders Drugs Status and Prospect (2012-2022)
  1.4.5 Japan Metabolic Disorders Drugs Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Metabolic Disorders Drugs Status and Prospect (2012-2022)
  1.4.7 India Metabolic Disorders Drugs Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Metabolic Disorders Drugs (2012-2022)
  1.5.1 Global Metabolic Disorders Drugs Sales and Growth Rate (2012-2022)
  1.5.2 Global Metabolic Disorders Drugs Revenue and Growth Rate (2012-2022)

2 GLOBAL METABOLIC DISORDERS DRUGS COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Metabolic Disorders Drugs Market Competition by Players/Suppliers
  2.1.1 Global Metabolic Disorders Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Global Metabolic Disorders Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Metabolic Disorders Drugs (Volume and Value) by Type
  2.2.1 Global Metabolic Disorders Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 Global Metabolic Disorders Drugs Revenue and Market Share by Type (2012-2017)
2.3 Global Metabolic Disorders Drugs (Volume and Value) by Region
  2.3.1 Global Metabolic Disorders Drugs Sales and Market Share by Region (2012-2017)
  2.3.2 Global Metabolic Disorders Drugs Revenue and Market Share by Region (2012-2017)
2.4 Global Metabolic Disorders Drugs (Volume) by Application

3 UNITED STATES METABOLIC DISORDERS DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 United States Metabolic Disorders Drugs Sales and Value (2012-2017)
  3.1.1 United States Metabolic Disorders Drugs Sales and Growth Rate (2012-2017)
  3.1.2 United States Metabolic Disorders Drugs Revenue and Growth Rate (2012-2017)
  3.1.3 United States Metabolic Disorders Drugs Sales Price Trend (2012-2017)
3.2 United States Metabolic Disorders Drugs Sales Volume and Market Share by Players
3.3 United States Metabolic Disorders Drugs Sales Volume and Market Share by Type
3.4 United States Metabolic Disorders Drugs Sales Volume and Market Share by Application

4 CHINA METABOLIC DISORDERS DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 China Metabolic Disorders Drugs Sales and Value (2012-2017)
  4.1.1 China Metabolic Disorders Drugs Sales and Growth Rate (2012-2017)
  4.1.2 China Metabolic Disorders Drugs Revenue and Growth Rate (2012-2017)
  4.1.3 China Metabolic Disorders Drugs Sales Price Trend (2012-2017)
4.2 China Metabolic Disorders Drugs Sales Volume and Market Share by Players
4.3 China Metabolic Disorders Drugs Sales Volume and Market Share by Type
4.4 China Metabolic Disorders Drugs Sales Volume and Market Share by Application

5 EUROPE METABOLIC DISORDERS DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Metabolic Disorders Drugs Sales and Value (2012-2017)
  5.1.1 Europe Metabolic Disorders Drugs Sales and Growth Rate (2012-2017)
  5.1.2 Europe Metabolic Disorders Drugs Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Metabolic Disorders Drugs Sales Price Trend (2012-2017)
5.2 Europe Metabolic Disorders Drugs Sales Volume and Market Share by Players
5.3 Europe Metabolic Disorders Drugs Sales Volume and Market Share by Type
5.4 Europe Metabolic Disorders Drugs Sales Volume and Market Share by Application

6 JAPAN METABOLIC DISORDERS DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Metabolic Disorders Drugs Sales and Value (2012-2017)
  6.1.1 Japan Metabolic Disorders Drugs Sales and Growth Rate (2012-2017)
  6.1.2 Japan Metabolic Disorders Drugs Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Metabolic Disorders Drugs Sales Price Trend (2012-2017)
6.2 Japan Metabolic Disorders Drugs Sales Volume and Market Share by Players
6.3 Japan Metabolic Disorders Drugs Sales Volume and Market Share by Type
6.4 Japan Metabolic Disorders Drugs Sales Volume and Market Share by Application

7 SOUTHEAST ASIA METABOLIC DISORDERS DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Metabolic Disorders Drugs Sales and Value (2012-2017)
  7.1.1 Southeast Asia Metabolic Disorders Drugs Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Metabolic Disorders Drugs Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Metabolic Disorders Drugs Sales Price Trend (2012-2017)
7.2 Southeast Asia Metabolic Disorders Drugs Sales Volume and Market Share by Players
7.3 Southeast Asia Metabolic Disorders Drugs Sales Volume and Market Share by Type
7.4 Southeast Asia Metabolic Disorders Drugs Sales Volume and Market Share by Application

8 INDIA METABOLIC DISORDERS DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 India Metabolic Disorders Drugs Sales and Value (2012-2017)
  8.1.1 India Metabolic Disorders Drugs Sales and Growth Rate (2012-2017)
  8.1.2 India Metabolic Disorders Drugs Revenue and Growth Rate (2012-2017)
  8.1.3 India Metabolic Disorders Drugs Sales Price Trend (2012-2017)
8.2 India Metabolic Disorders Drugs Sales Volume and Market Share by Players
8.3 India Metabolic Disorders Drugs Sales Volume and Market Share by Type
8.4 India Metabolic Disorders Drugs Sales Volume and Market Share by Application

9 GLOBAL METABOLIC DISORDERS DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Zealand Pharma
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Metabolic Disorders Drugs Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Zealand Pharma Metabolic Disorders Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 Rhythm
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Metabolic Disorders Drugs Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Rhythm Metabolic Disorders Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 OxThera
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Metabolic Disorders Drugs Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 OxThera Metabolic Disorders Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 Biophytis
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Metabolic Disorders Drugs Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Biophytis Metabolic Disorders Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 Biophytis
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Metabolic Disorders Drugs Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Biophytis Metabolic Disorders Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 Zafgen
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Metabolic Disorders Drugs Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 Zafgen Metabolic Disorders Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview
9.7 PerkinElmer
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Metabolic Disorders Drugs Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 PerkinElmer Metabolic Disorders Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.7.4 Main Business/Business Overview
9.8 Eternygen
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Metabolic Disorders Drugs Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Eternygen Metabolic Disorders Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.8.4 Main Business/Business Overview
9.9 Pronutria Biosciences
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Metabolic Disorders Drugs Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 Pronutria Biosciences Metabolic Disorders Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.9.4 Main Business/Business Overview
9.10 MedGenome
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Metabolic Disorders Drugs Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 MedGenome Metabolic Disorders Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.10.4 Main Business/Business Overview
9.11 CellCentric
9.12 Nimbus Therapeutics
9.13 Mitobridge
9.14 Exelixis, Inc.
9.15 Outpost Medicine
9.16 Anchor Therapeutics
9.17 Verva Pharmaceuticals

10 METABOLIC DISORDERS DRUGS MAUFACTURING COST ANALYSIS

10.1 Metabolic Disorders Drugs Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Metabolic Disorders Drugs
10.3 Manufacturing Process Analysis of Metabolic Disorders Drugs

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Metabolic Disorders Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Metabolic Disorders Drugs Major Manufacturers in 2016
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL METABOLIC DISORDERS DRUGS MARKET FORECAST (2017-2022)

14.1 Global Metabolic Disorders Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Metabolic Disorders Drugs Sales Volume and Growth Rate Forecast (2017-2022)
  14.1.2 Global Metabolic Disorders Drugs Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Metabolic Disorders Drugs Price and Trend Forecast (2017-2022)
14.2 Global Metabolic Disorders Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  14.2.1 Global Metabolic Disorders Drugs Sales Volume and Growth Rate Forecast by Regions (2017-2022)
  14.2.2 Global Metabolic Disorders Drugs Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.3 United States Metabolic Disorders Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 China Metabolic Disorders Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Europe Metabolic Disorders Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 Japan Metabolic Disorders Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.7 Southeast Asia Metabolic Disorders Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.8 India Metabolic Disorders Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Metabolic Disorders Drugs Sales Volume, Revenue and Price Forecast by Type (2017-2022)
  14.3.1 Global Metabolic Disorders Drugs Sales Forecast by Type (2017-2022)
  14.3.2 Global Metabolic Disorders Drugs Revenue Forecast by Type (2017-2022)
  14.3.3 Global Metabolic Disorders Drugs Price Forecast by Type (2017-2022)
14.4 Global Metabolic Disorders Drugs Sales Volume Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Metabolic Disorders Drugs
Figure Global Metabolic Disorders Drugs Sales Volume Comparison (K Pcs) by Type (2012-2022)
Figure Global Metabolic Disorders Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Tablet Product Picture
Figure Injection Product Picture
Figure Global Metabolic Disorders Drugs Sales Comparison (K Pcs) by Application (2012-2022)
Figure Global Sales Market Share of Metabolic Disorders Drugs by Application in 2016
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Disorders of the Thyroid and Pituitary Gland Examples
Table Key Downstream Customer in Disorders of the Thyroid and Pituitary Gland
Figure Other Examples
Table Key Downstream Customer in Other
Figure Global Metabolic Disorders Drugs Market Size (Million USD) by Regions (2012-2022)
Figure United States Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Metabolic Disorders Drugs Sales Volume (K Pcs) and Growth Rate (2012-2022)
Figure Global Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Metabolic Disorders Drugs Sales Volume (K Pcs) (2012-2017)
Table Global Metabolic Disorders Drugs Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table Global Metabolic Disorders Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Metabolic Disorders Drugs Sales Share by Players/Suppliers
Figure 2017 Metabolic Disorders Drugs Sales Share by Players/Suppliers
Figure Global Metabolic Disorders Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Metabolic Disorders Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Metabolic Disorders Drugs Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Metabolic Disorders Drugs Revenue Share by Players
Table 2017 Global Metabolic Disorders Drugs Revenue Share by Players
Table Global Metabolic Disorders Drugs Sales (K Pcs) and Market Share by Type (2012-2017)
Table Global Metabolic Disorders Drugs Sales Share (K Pcs) by Type (2012-2017)
Figure Sales Market Share of Metabolic Disorders Drugs by Type (2012-2017)
Figure Global Metabolic Disorders Drugs Sales Growth Rate by Type (2012-2017)
Table Global Metabolic Disorders Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Metabolic Disorders Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Metabolic Disorders Drugs by Type (2012-2017)
Figure Global Metabolic Disorders Drugs Revenue Growth Rate by Type (2012-2017)
Table Global Metabolic Disorders Drugs Sales Volume (K Pcs) and Market Share by Region (2012-2017)
Table Global Metabolic Disorders Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Metabolic Disorders Drugs by Region (2012-2017)
Figure Global Metabolic Disorders Drugs Sales Growth Rate by Region in 2016
Table Global Metabolic Disorders Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Metabolic Disorders Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Metabolic Disorders Drugs by Region (2012-2017)
Figure Global Metabolic Disorders Drugs Revenue Growth Rate by Region in 2016
Table Global Metabolic Disorders Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Metabolic Disorders Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Metabolic Disorders Drugs by Region (2012-2017)
Figure Global Metabolic Disorders Drugs Revenue Market Share by Region in 2016
Table Global Metabolic Disorders Drugs Sales Volume (K Pcs) and Market Share by Application (2012-2017)
Table Global Metabolic Disorders Drugs Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Metabolic Disorders Drugs by Application (2012-2017)
Figure Global Metabolic Disorders Drugs Sales Market Share by Application (2012-2017)
Figure United States Metabolic Disorders Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure United States Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Metabolic Disorders Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table United States Metabolic Disorders Drugs Sales Volume (K Pcs) by Players (2012-2017)
Table United States Metabolic Disorders Drugs Sales Volume Market Share by Players (2012-2017)
Figure United States Metabolic Disorders Drugs Sales Volume Market Share by Players in 2016
Table United States Metabolic Disorders Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table United States Metabolic Disorders Drugs Sales Volume Market Share by Type (2012-2017)
Figure United States Metabolic Disorders Drugs Sales Volume Market Share by Type in 2016
Table United States Metabolic Disorders Drugs Sales Volume (K Pcs) by Application (2012-2017)
Table United States Metabolic Disorders Drugs Sales Volume Market Share by Application (2012-2017)
Figure United States Metabolic Disorders Drugs Sales Volume Market Share by Application in 2016
Figure China Metabolic Disorders Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure China Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Metabolic Disorders Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table China Metabolic Disorders Drugs Sales Volume (K Pcs) by Players (2012-2017)
Table China Metabolic Disorders Drugs Sales Volume Market Share by Players (2012-2017)
Figure China Metabolic Disorders Drugs Sales Volume Market Share by Players in 2016
Table China Metabolic Disorders Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table China Metabolic Disorders Drugs Sales Volume Market Share by Type (2012-2017)
Figure China Metabolic Disorders Drugs Sales Volume Market Share by Type in 2016
Table China Metabolic Disorders Drugs Sales Volume (K Pcs) by Application (2012-2017)
Table China Metabolic Disorders Drugs Sales Volume Market Share by Application (2012-2017)
Figure China Metabolic Disorders Drugs Sales Volume Market Share by Application in 2016
Figure Europe Metabolic Disorders Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Metabolic Disorders Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table Europe Metabolic Disorders Drugs Sales Volume (K Pcs) by Players (2012-2017)
Table Europe Metabolic Disorders Drugs Sales Volume Market Share by Players (2012-2017)
Figure Europe Metabolic Disorders Drugs Sales Volume Market Share by Players in 2016
Table Europe Metabolic Disorders Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table Europe Metabolic Disorders Drugs Sales Volume Market Share by Type (2012-2017)
Figure Europe Metabolic Disorders Drugs Sales Volume Market Share by Type in 2016
Table Europe Metabolic Disorders Drugs Sales Volume (K Pcs) by Application (2012-2017)
Table Europe Metabolic Disorders Drugs Sales Volume Market Share by Application (2012-2017)
Figure Europe Metabolic Disorders Drugs Sales Volume Market Share by Application in 2016
Figure Japan Metabolic Disorders Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Japan Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Metabolic Disorders Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table Japan Metabolic Disorders Drugs Sales Volume (K Pcs) by Players (2012-2017)
Table Japan Metabolic Disorders Drugs Sales Volume Market Share by Players (2012-2017)
Figure Japan Metabolic Disorders Drugs Sales Volume Market Share by Players in 2016
Table Japan Metabolic Disorders Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table Japan Metabolic Disorders Drugs Sales Volume Market Share by Type (2012-2017)
Figure Japan Metabolic Disorders Drugs Sales Volume Market Share by Type in 2016
Table Japan Metabolic Disorders Drugs Sales Volume (K Pcs) by Application (2012-2017)
Table Japan Metabolic Disorders Drugs Sales Volume Market Share by Application (2012-2017)
Figure Japan Metabolic Disorders Drugs Sales Volume Market Share by Application in 2016
Figure Southeast Asia Metabolic Disorders Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Southeast Asia Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Metabolic Disorders Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table Southeast Asia Metabolic Disorders Drugs Sales Volume (K Pcs) by Players (2012-2017)
Table Southeast Asia Metabolic Disorders Drugs Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Metabolic Disorders Drugs Sales Volume Market Share by Players in 2016
Table Southeast Asia Metabolic Disorders Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table Southeast Asia Metabolic Disorders Drugs Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Metabolic Disorders Drugs Sales Volume Market Share by Type in 2016
Table Southeast Asia Metabolic Disorders Drugs Sales Volume (K Pcs) by Application (2012-2017)
Table Southeast Asia Metabolic Disorders Drugs Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Metabolic Disorders Drugs Sales Volume Market Share by Application in 2016
Figure India Metabolic Disorders Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure India Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Metabolic Disorders Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table India Metabolic Disorders Drugs Sales Volume (K Pcs) by Players (2012-2017)
Table India Metabolic Disorders Drugs Sales Volume Market Share by Players (2012-2017)
Figure India Metabolic Disorders Drugs Sales Volume Market Share by Players in 2016
Table India Metabolic Disorders Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table India Metabolic Disorders Drugs Sales Volume Market Share by Type (2012-2017)
Figure India Metabolic Disorders Drugs Sales Volume Market Share by Type in 2016
Table India Metabolic Disorders Drugs Sales Volume (K Pcs) by Application (2012-2017)
Table India Metabolic Disorders Drugs Sales Volume Market Share by Application (2012-2017)
Figure India Metabolic Disorders Drugs Sales Volume Market Share by Application in 2016
Table Zealand Pharma Basic Information List
Table Zealand Pharma Metabolic Disorders Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Zealand Pharma Metabolic Disorders Drugs Sales Growth Rate (2012-2017)
Figure Zealand Pharma Metabolic Disorders Drugs Sales Global Market Share (2012-2017
Figure Zealand Pharma Metabolic Disorders Drugs Revenue Global Market Share (2012-2017)
Table Rhythm Basic Information List
Table Rhythm Metabolic Disorders Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Rhythm Metabolic Disorders Drugs Sales Growth Rate (2012-2017)
Figure Rhythm Metabolic Disorders Drugs Sales Global Market Share (2012-2017
Figure Rhythm Metabolic Disorders Drugs Revenue Global Market Share (2012-2017)
Table OxThera Basic Information List
Table OxThera Metabolic Disorders Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure OxThera Metabolic Disorders Drugs Sales Growth Rate (2012-2017)
Figure OxThera Metabolic Disorders Drugs Sales Global Market Share (2012-2017
Figure OxThera Metabolic Disorders Drugs Revenue Global Market Share (2012-2017)
Table Biophytis Basic Information List
Table Biophytis Metabolic Disorders Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Biophytis Metabolic Disorders Drugs Sales Growth Rate (2012-2017)
Figure Biophytis Metabolic Disorders Drugs Sales Global Market Share (2012-2017
Figure Biophytis Metabolic Disorders Drugs Revenue Global Market Share (2012-2017)
Table Biophytis Basic Information List
Table Biophytis Metabolic Disorders Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Biophytis Metabolic Disorders Drugs Sales Growth Rate (2012-2017)
Figure Biophytis Metabolic Disorders Drugs Sales Global Market Share (2012-2017
Figure Biophytis Metabolic Disorders Drugs Revenue Global Market Share (2012-2017)
Table Zafgen Basic Information List
Table Zafgen Metabolic Disorders Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Zafgen Metabolic Disorders Drugs Sales Growth Rate (2012-2017)
Figure Zafgen Metabolic Disorders Drugs Sales Global Market Share (2012-2017
Figure Zafgen Metabolic Disorders Drugs Revenue Global Market Share (2012-2017)
Table PerkinElmer Basic Information List
Table PerkinElmer Metabolic Disorders Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure PerkinElmer Metabolic Disorders Drugs Sales Growth Rate (2012-2017)
Figure PerkinElmer Metabolic Disorders Drugs Sales Global Market Share (2012-2017
Figure PerkinElmer Metabolic Disorders Drugs Revenue Global Market Share (2012-2017)
Table Eternygen Basic Information List
Table Eternygen Metabolic Disorders Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eternygen Metabolic Disorders Drugs Sales Growth Rate (2012-2017)
Figure Eternygen Metabolic Disorders Drugs Sales Global Market Share (2012-2017
Figure Eternygen Metabolic Disorders Drugs Revenue Global Market Share (2012-2017)
Table Pronutria Biosciences Basic Information List
Table Pronutria Biosciences Metabolic Disorders Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pronutria Biosciences Metabolic Disorders Drugs Sales Growth Rate (2012-2017)
Figure Pronutria Biosciences Metabolic Disorders Drugs Sales Global Market Share (2012-2017
Figure Pronutria Biosciences Metabolic Disorders Drugs Revenue Global Market Share (2012-2017)
Table MedGenome Basic Information List
Table MedGenome Metabolic Disorders Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure MedGenome Metabolic Disorders Drugs Sales Growth Rate (2012-2017)
Figure MedGenome Metabolic Disorders Drugs Sales Global Market Share (2012-2017
Figure MedGenome Metabolic Disorders Drugs Revenue Global Market Share (2012-2017)
Table CellCentric Basic Information List
Table Nimbus Therapeutics Basic Information List
Table Mitobridge Basic Information List
Table Exelixis, Inc. Basic Information List
Table Outpost Medicine Basic Information List
Table Anchor Therapeutics Basic Information List
Table Verva Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Metabolic Disorders Drugs
Figure Manufacturing Process Analysis of Metabolic Disorders Drugs
Figure Metabolic Disorders Drugs Industrial Chain Analysis
Table Raw Materials Sources of Metabolic Disorders Drugs Major Players in 2016
Table Major Buyers of Metabolic Disorders Drugs
Table Distributors/Traders List
Figure Global Metabolic Disorders Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Global Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Metabolic Disorders Drugs Price (USD/Pcs) and Trend Forecast (2017-2022)
Table Global Metabolic Disorders Drugs Sales Volume (K Pcs) Forecast by Regions (2017-2022)
Figure Global Metabolic Disorders Drugs Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Metabolic Disorders Drugs Sales Volume Market Share Forecast by Regions in 2022
Table Global Metabolic Disorders Drugs Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Metabolic Disorders Drugs Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Metabolic Disorders Drugs Revenue Market Share Forecast by Regions in 2022
Figure United States Metabolic Disorders Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Metabolic Disorders Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Metabolic Disorders Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Metabolic Disorders Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Europe Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Metabolic Disorders Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Metabolic Disorders Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Metabolic Disorders Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Metabolic Disorders Drugs Sales (K Pcs) Forecast by Type (2017-2022)
Figure Global Metabolic Disorders Drugs Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Metabolic Disorders Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Metabolic Disorders Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Global Metabolic Disorders Drugs Price (USD/Pcs) Forecast by Type (2017-2022)
Table Global Metabolic Disorders Drugs Sales (K Pcs) Forecast by Application (2017-2022)
Figure Global Metabolic Disorders Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources